Skip to content

Gut Microbiota-Mediated Mechanisms of Qingchang Xiaopi Decoction in Dampness-Heat Syndrome Ulcerative Colitis

Gut Microbiota-Mediated Mechanisms of Qingchang Xiaopi Decoction in Dampness-Heat Syndrome Ulcerative Colitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000307
Enrollment
Unknown
Registered
2025-02-17
Start date
2025-02-28
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis

Interventions

Treament group:Qingchang Xiaopi Decoction

Sponsors

The Affiliated Dongguan Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-70 years with no gender restriction; 2. Diagnosed with ulcerative colitis according to established criteria; 3. Presenting mild to moderate active phase of ulcerative colitis; 4. Meeting diagnostic standards for Large Intestine Dampness-Heat Syndrome; 5. Provision of signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with infectious colitis (e.g. chronic schistosomiasis bacillary dysentery intestinal tuberculosis) or other intestinal disorders including Crohn's disease radiation-induced enteritis and ischemic colitis; 2. Lactating or pregnant individuals or those with medication intolerance; 3. Severe primary diseases affecting major organ systems (cardiac pulmonary hepatic renal or hematopoietic) or psychiatric disorders; 4. Severe complications such as intestinal strictures toxic megacolon bowel obstruction colorectal cancer intestinal perforation or anorectal pathologies; 5. Legally defined disabilities (e.g. mutism deafness blindness physical disabilities intellectual impairments).

Design outcomes

Primary

MeasureTime frame
Metagenomic analysis;Viral Metagenomics;

Secondary

MeasureTime frame
Disease remission rate;Single symptom efficacy;Disease recurrence rate;C-reactive protein;inflammatory bowel disease questionnaire;Traditional Chinese Medicine Syndrome Efficacy;erythrocyte sedimentation rate;

Countries

China

Contacts

Public ContactZhi-Ning Ye

The Affiliated Dongguan Hospital of Guangzhou University of Chinese Medicine

1554520250@qq.com15627862076

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026